Study guide

13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome

CBCN Certified Breast Care Nurse Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The CBCN Exam

CBCN Exam Facts, 2026 Blueprint & Study Plan

2 Chapter 1: Breast Health, Examination & Benign Conditions (Care Continuum)

1.1 Breast Anatomy, Vascular Supply & Hormonal Physiology 1.2 Clinical Breast Examination & Breast Awareness Education 1.3 Benign Breast Conditions, Mastalgia & Fibrocystic Changes

3 Chapter 2: Screening, Breast Density & Special Populations (Care Continuum)

2.1 Screening Modalities, Breast Density & Pharmacologic Risk Reduction 2.2 Screening & Breast Health in Special Populations

4 Chapter 3: Cancer Risk Assessment & Genetics (Care Continuum)

3.1 Proliferative Lesions, Atypia & High-Risk Benign Pathology 3.2 Breast Cancer Risk Models (Gail, Tyrer-Cuzick, Claus, BRCAPRO) 3.3 Hereditary Cancer Syndromes & Genetic Evaluation

5 Chapter 4: Patient Navigation, Surveillance & Survivorship (Care Continuum)

4.1 Patient Navigation, Barriers to Care, Social Determinants & Interprofessional Collaboration 4.2 Survivorship Care Planning, Surveillance Intervals & Recurrence Monitoring 4.3 Secondary Prevention, Physical Activity, Nutrition & Wellness Guidance

6 Chapter 5: Carcinogenesis & Diagnostic Evaluation (Diagnosis and Staging)

5.1 Carcinogenesis: How Breast Cancer Develops and Spreads 5.2 Clinical Assessment, Diagnostic Imaging & BI-RADS Categorization 5.3 Breast Biopsy Modalities & Image-Guided Localization Techniques

7 Chapter 6: Pathology, Biomarkers & Genomic Testing (Diagnosis and Staging)

6.1 Histopathology: In Situ Carcinomas & Invasive Carcinoma Subtypes 6.2 Receptor Biomarkers (ER, PR, HER2, Ki-67) & Molecular Subtypes 6.3 Multigene Genomic Assays & Recurrence Risk Stratification

8 Chapter 7: Clinical & Pathologic Staging (Diagnosis and Staging)

7.1 AJCC TNM Staging System (Anatomic vs Prognostic Staging) 7.2 Staging Workup: When to Use MRI, CT, Bone Scan & PET

9 Chapter 8: Breast Surgery, Axillary Staging & Reconstruction (Treatment Modalities)

8.1 Breast-Conserving Surgery, Margin Standards & Mastectomy Techniques 8.2 Axillary Staging: Sentinel Lymph Node Biopsy vs. Axillary Dissection 8.3 Post-Mastectomy Reconstruction & Oncoplastic Surgery

10 Chapter 9: Radiation Therapy & Chemotherapy (Treatment Modalities)

9.1 Radiation Therapy: Whole Breast, Chest Wall, Regional Nodal & Partial Breast Irradiation 9.2 Neoadjuvant vs. Adjuvant Chemotherapy Principles & Standard Regimens

11 Chapter 10: Endocrine, HER2-Targeted & Novel Systemic Therapies (Treatment Modalities)

10.1 Endocrine Therapy: SERMs, Aromatase Inhibitors, Ovarian Suppression & SERDs 10.2 HER2-Targeted Monoclonal Antibodies, Antibody-Drug Conjugates & Kinase Inhibitors 10.3 CDK4/6 Inhibitors, PARP Inhibitors & Immune Checkpoint Blockade 10.4 Trop-2 Antibody-Drug Conjugates, PI3K/AKT/mTOR Inhibitors & New Oral SERDs

12 Chapter 11: Specific Conditions & Special Populations (Treatment Modalities)

11.1 Triple-Negative Breast Cancer: Treatment Considerations 11.2 HER2-Positive Breast Cancer: Treatment Considerations 11.3 Inflammatory Breast Cancer & Paget Disease of the Nipple 11.4 Phyllodes Tumors & Breast Angiosarcoma 11.5 Treatment Considerations for Special Populations

13 Chapter 12: Symptom Management & Supportive Care (Nursing Practice)

12.1 Acute Chemotherapy Toxicities, Supportive Regimens & Oncologic Emergencies 12.2 Lymphedema Pathophysiology, ISL Staging & Complete Decongestive Therapy (CDT) 12.3 Musculoskeletal Toxicities, Bone Health & Vasomotor/GSM Relief 12.4 Complementary & Integrative Modalities 12.5 Cancer Rehabilitation: Physical, Occupational & Pelvic Floor Therapy

14 Chapter 13: Oncologic Emergencies (Nursing Practice)

13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome 13.2 Oncologic Emergencies II: Hypersensitivity & Anaphylaxis, Sepsis, Pleural Effusion & Thromboembolism

15 Chapter 14: Professional Practice, Clinical Trials & Self-Care (Nursing Practice)

14.1 Professional Practice: Guidelines, Ethics, Legislation, Outreach & Accreditation 14.2 Clinical Trials in Breast Oncology 14.3 Nurse Self-Care: Compassion Fatigue, Burnout, Moral Distress & Substance Use

16 Chapter 15: Psychosocial Dimensions of Care (Psychosocial Dimensions)

15.1 Psychosocial Distress, Coping, Grief & Palliative Care 15.2 Culture, Spirituality, Sexual & Gender Identity, Age & Healthcare Disparities 15.3 Family & Caregiver Dynamics 15.4 Altered Body Image 15.5 Reproductive & Sexual Health

13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome

Key Takeaways Explain This Topic AI

Back pain that worsens when lying down in a patient with bone metastases is malignant spinal cord compression until proven otherwise and requires same-day dexamethasone and MRI of the entire spine.

Ambulatory status at the time of diagnosis is the strongest predictor of walking after treatment for spinal cord compression, so delays cost function.

Corrected calcium equals measured calcium plus 0.8 times (4.0 minus albumin), and first-line treatment of hypercalcemia of malignancy is aggressive IV normal saline followed by a bone-modifying agent.

Cardiac tamponade presents with Beck's triad (hypotension, jugular venous distention, muffled heart sounds) plus pulsus paradoxus and is treated with emergent pericardiocentesis.

Last updated: October 2026

Overview

Metastatic breast cancer frequently involves bone, pleura, pericardium, and mediastinal nodes, so breast care nurses must recognize structural and metabolic emergencies quickly, often by phone triage. Hypersensitivity reactions, sepsis, malignant pleural effusion, and thromboembolism are covered in the next section; febrile neutropenia and extravasation are covered with chemotherapy toxicities.

Oncologic Emergencies in Breast Oncology

Certified breast care nurses must recognize and respond to these four structural and metabolic emergencies immediately:

1. Malignant Spinal Cord Compression (MSCC)

Occurs in 5% to 10% of patients with advanced metastatic breast cancer, arising when vertebral bone metastases expand into the epidural space, mechanically compressing the thecal sac and spinal cord (thoracic spine ~70%, lumbosacral ~20%, cervical ~10%):

Clinical Presentation: Progressive back pain is the initial symptom in >95% of cases. Crucially, MSCC back pain worsens when recumbent (lying supine in bed) due to distention of the epidural venous plexus and is exacerbated by coughing, straining, or percussion. Subsequent signs include motor weakness (difficulty ambulating, leg "heaviness"), sensory impairment with a distinct sensory level, and late autonomic dysfunction (urinary retention, overflow incontinence, loss of anal sphincter tone).

Emergency Nursing Management: Immediate administration of intravenous dexamethasone (10 to 16 mg IV bolus followed by 4 to 8 mg every 6 hours) to reduce vasogenic cord edema; emergent MRI of the entire spine within 24 hours (skip lesions occur in up to 30% of patients); urgent radiation oncology and spine surgery consultation for emergent decompression and stabilization.

2. Hypercalcemia of Malignancy (HCM)

One of the most common metabolic emergencies in metastatic breast cancer, especially with extensive bone metastases, mediated by tumor secretion of parathyroid hormone-related peptide (PTHrP) or osteolytic bone destruction:

Clinical Manifestations: "Bones, stones, abdominal groans, and psychic moans." Anorexia, nausea, vomiting, severe constipation, polyuria, polydipsia, dehydration, muscle weakness, confusion, delirium, stupor, and cardiac dysrhythmias (shortened QT interval).

Diagnostic Metric: Corrected Calcium = Measured Serum Calcium + [0.8 × (4.0 - Serum Albumin)]. A corrected calcium >10.5 mg/dL is abnormal; >14.0 mg/dL represents a life-threatening crisis.

Emergency Protocols:

Aggressive Hydration: Immediate infusion of 0.9% normal saline at 200 to 500 mL/hr to restore intravascular volume and promote renal calciuresis.

Antiresorptive Therapy: Intravenous zoledronic acid (4 mg over 15 minutes) or subcutaneous denosumab (120 mg on days 1, 8, 15, then monthly; preferred in renal insufficiency). Onset is 48 to 72 hours.

Calcitonin: Subcutaneous/IM calcitonin (4 to 8 IU/kg every 12 hours) provides rapid calcium reduction within 2 to 4 hours (tachyphylaxis occurs after 48 hours).

Loop Diuretics: Furosemide is strictly indicated only after complete intravascular volume rehydration is achieved and fluid overload threatens.

3. Malignant Pericardial Effusion and Cardiac Tamponade

Metastatic seeding of the pericardium leads to rapid fluid accumulation, restricting ventricular filling. Manifests with Beck's triad (hypotension, jugular venous distention, and distant/muffled heart sounds), tachycardia, dyspnea, and pulsus paradoxus (>10 mmHg systolic drop on inspiration). Managed via emergent pericardiocentesis or surgical pericardial window.

4. Superior Vena Cava (SVC) Syndrome

Extrinsic compression of the superior vena cava by mediastinal lymphadenopathy or tumor thrombus impairs venous return from the head, neck, and upper extremities. Manifests as progressive facial and periorbital edema, plethora, distended neck and thoracic veins, dyspnea, and cough. Managed with head-of-bed elevation, supplemental oxygen, emergency radiation therapy, or endovascular stenting.

Emergency Summary Table

Oncologic Emergency Pathophysiologic Mechanism Hallmark Signs & Clinical Red Flags Immediate Emergency Interventions & Nursing Actions

Malignant Spinal Cord Compression (MSCC) Epidural tumor expansion compressing spinal cord (most common in thoracic spine) Back pain worsening when recumbent; progressive motor weakness; bowel/bladder incontinence Immediate IV dexamethasone (10–16 mg bolus); emergent MRI of entire spine; urgent rad onc/spine consult

Hypercalcemia of Malignancy (HCM) Osteolytic bone breakdown or tumor PTHrP secretion; corrected calcium >10.5 mg/dL Confusion, lethargy, obstipation, nausea, polyuria, dehydration, shortened QT interval Aggressive IV 0.9% normal saline (200–500 mL/hr); IV zoledronic acid 4 mg; calcitonin; loop diuretics only after full rehydration

Cardiac Tamponade Fluid accumulation in pericardial space restricting ventricular filling Beck's triad (hypotension, JVD, muffled heart sounds); pulsus paradoxus; tachypnea Immediate echocardiogram; emergent bedside pericardiocentesis; continuous hemodynamic monitoring

Superior Vena Cava (SVC) Syndrome Mediastinal metastasis compressing SVC, impeding venous return from head/chest Facial/periorbital edema, plethora, distended chest wall veins, orthopnea Elevate head of bed; high-flow oxygen; emergency radiation therapy or endovascular venous stenting

  • Additional Management Details
  • Spinal Cord Compression

Outcome predictor: patients who walk at diagnosis usually keep walking after treatment; patients who are paraplegic for more than about 24 to 48 hours rarely recover. This is why triage must be same-day.

Definitive treatment: radiation is standard (for example, a single 8-Gy fraction or 20 Gy in 5 fractions for patients with limited survival); decompressive surgery followed by radiation benefits selected patients with a single level of compression, spinal instability, or radioresistant disease.

Nursing care: spinal precautions and log-rolling if instability is suspected, frequent neurologic checks (motor strength, sensory level, bowel and bladder function), bladder scanning for retention, bowel regimen, VTE prophylaxis, pain control, and steroid side-effect monitoring (hyperglycemia, gastric protection, mood changes).

Hypercalcemia of Malignancy

Mechanisms: PTH-related peptide secretion (humoral hypercalcemia) and osteolytic bone metastases are the main causes in breast cancer.

Rehydration goal: isotonic saline to restore volume and maintain a brisk urine output (commonly around 100 to 150 mL per hour), with careful monitoring in heart or kidney disease.

Bone-modifying agents: zoledronic acid (used with caution and close creatinine monitoring in renal impairment) or denosumab, which is not cleared by the kidneys but carries a higher risk of hypocalcemia. Calcium falls over 2 to 4 days, so calcitonin bridges the first 48 hours.

Monitoring: calcium, albumin, creatinine, magnesium, and phosphorus; mental status; strict intake and output; fall precautions.

Prevention: in patients with bone metastases, regular bone-modifying agents reduce skeletal-related events, and patients should stay hydrated and mobile.

Malignant Pericardial Effusion and Tamponade

Breast and lung cancers are the most common solid tumors causing malignant pericardial effusion. Slowly accumulating fluid may cause only fatigue and dyspnea until tamponade develops. Echocardiography confirms the diagnosis. After pericardiocentesis, recurrence is common, so a pericardial drain, pericardial window, or sclerosis may follow. Nurses monitor vital signs, pulsus paradoxus, drain output, and signs of reaccumulation.

Superior Vena Cava Syndrome

SVC syndrome is less common in breast cancer than in lung cancer or lymphoma but can occur with mediastinal nodal disease or catheter-related thrombosis. Most cases develop over weeks and are urgent rather than immediately life-threatening, unless there is airway compromise or cerebral edema. Endovascular stenting gives the fastest symptom relief; radiation and systemic therapy treat the underlying tumor, and anticoagulation is used for thrombosis. Avoid blood pressure measurements and IV access in the arms when upper-extremity venous flow is obstructed.